Wed, June 10, 2023 08:30 CET Biohit Oyj Half Year Financial Report 10 June 2023 at 9:30 am local time (EET)
SUMMARY January-June 2023 Revenue EUR 6.1 million (EUR 4.0 million) Revenue increased by 53% compared to H1/2021 Operative EBITDA EUR 1.7 million (EUR -0.2 million) Cash at the end of the period EUR 1.6 million (EUR 1.1 million 31 December 2021) Fair value of Genetic Analysis AS investment EUR 0.4 million (EUR 0.9 million 31 December 2021) Revenue from international operations 98.2% (97.2%) of total revenue Equity ratio 70.
BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2023
